Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
13 Cards in this Set
- Front
- Back
Pathophysiology
|
Loss of SUBSANTIA NIGRA NEURONS
Loss of dopaegernic projections to the striatum |
|
Environmental Factors
|
Pesticides
Toxins: MPTP Well Water Head Trauma Smoking/coffee=protection |
|
Genetic factors
|
Genetic component more obvious with early onset cases
Most likely a complex interaction with many other genes |
|
Basal Ganglia
|
collection of nuclei in forebrain that make connections with motor cortex and the midbrain
|
|
Pathology of Parkinson's
|
Loss of neurons in the NIGRO STRIATAL PATHWAY
----Substantia niagra has dopamine containing neurons ----Project to the Basal Ganglia Antipsychotics |
|
Pathophysiology
|
Loss of neurons in the substantia nigra
Loss of striatal dopamine |
|
Pathology of remaining neurons
|
--Lewy Bodies
--Mitochondrial Dysfunction |
|
Neuropharmalogical Treatment
|
1. Increase activity in dopamine synapses
2. suppress activity in structures with heightened activity (symptom oriented!) *Direct DA agonists *ACh antagonists *glutamate antagonists *MAO inhibitors |
|
L-DOPA
|
DA precursor
Mechanism of action: -converted into DA in the brain -Released by remaining neurons DOPAMINE DOES NOT CROSS THE BBB |
|
Problems with L-DOPA treatment
|
Converted into DA rapidly in the brain, so high doses are required, and high doses cause nausea
Long terms effects: dyskenesia (involuntary movement) and "on/off periods" |
|
Carbidopa
|
Delays the conversion of LDOPA
DOES NOT CROSS BBB Lower doses of LDOPA required, because more reaches the brain |
|
Other Treatments
|
1. MAO-B Inhibitors: boost effects of ldopa, controls metabolism in the brain,
2. COMT inhibitors: prolong symptom relief by postponing metabolism of L-Dopa |
|
GDNF
|
has been shown to reduce loss of DA neurons in rats
Protect neurons/Regenerate them? |